Here's What Key Metrics Tell Us About Douglas Emmett (DEI) Q2 Earnings

06.08.25 01:00 Uhr

Werte in diesem Artikel
Aktien

11,94 EUR 0,16 EUR 1,36%

14,10 EUR -0,10 EUR -0,70%

69,00 EUR -1,00 EUR -1,43%

Indizes

16.696,1 PKT 136,3 PKT 0,82%

16.714,2 PKT 152,4 PKT 0,92%

7.047,2 PKT 64,3 PKT 0,92%

Douglas Emmett (DEI) reported $252.43 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 2.7%. EPS of $0.37 for the same period compares to $0.06 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $251.14 million, representing a surprise of +0.52%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.37.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Douglas Emmett performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Total multifamily revenues: $49.62 million compared to the $48.48 million average estimate based on two analysts. The reported number represents a change of +6.6% year over year.Revenues- Total office revenues: $202.81 million compared to the $201.8 million average estimate based on two analysts. The reported number represents a change of +1.8% year over year.Net Earnings Per Share (Diluted): $-0.04 versus the four-analyst average estimate of $-0.06.View all Key Company Metrics for Douglas Emmett here>>>Shares of Douglas Emmett have returned -3.3% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Douglas Emmett, Inc. (DEI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Douglas

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Douglas

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Douglas AG

Wer­bung

Analysen zu Douglas AG

DatumRatingAnalyst
14.08.2025Douglas NeutralUBS AG
14.08.2025Douglas BuyDeutsche Bank AG
14.08.2025Douglas BuyJefferies & Company Inc.
14.07.2025Douglas BuyDeutsche Bank AG
15.05.2025Douglas NeutralUBS AG
DatumRatingAnalyst
14.08.2025Douglas BuyDeutsche Bank AG
14.08.2025Douglas BuyJefferies & Company Inc.
14.07.2025Douglas BuyDeutsche Bank AG
15.05.2025Douglas BuyDeutsche Bank AG
15.05.2025Douglas BuyJefferies & Company Inc.
DatumRatingAnalyst
14.08.2025Douglas NeutralUBS AG
15.05.2025Douglas NeutralUBS AG
26.03.2025Douglas NeutralUBS AG
23.01.2013DOUGLAS haltenequinet AG
14.12.2012DOUGLAS haltenIndependent Research GmbH
DatumRatingAnalyst
29.01.2013DOUGLAS verkaufenIndependent Research GmbH
05.12.2012DOUGLAS verkaufenFrankfurter Tagesdienst
04.12.2012DOUGLAS verkaufenNational-Bank AG
19.11.2012DOUGLAS reduceCommerzbank Corp. & Markets
16.10.2012DOUGLAS underperformCheuvreux SA

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Douglas AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen